The performance of companies tied to flagship drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the patent expiration in key regions has introduced significant volatility. Investors are now grappling with the consequences of ri